Dendritic cell immunotherapy: clinical outcomes

The use of tumour-associated antigens for cancer immunotherapy studies is exacerbated by tolerance to these self-antigens. Tolerance may be broken by using ex vivo monocyte-derived dendritic cells (DCs) pulsed with self-antigens. Targeting tumour-associated antigens directly to DCs in vivo is an alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Apostolopoulos, Vasso, Pietersz, Geoffrey A, Tsibanis, Anastasios, Tsikkinis, Annivas, Stojanovska, Lily, McKenzie, Ian FC, Vassilaros, Stamatis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232065/
https://www.ncbi.nlm.nih.gov/pubmed/25505969
http://dx.doi.org/10.1038/cti.2014.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232065/
https://www.ncbi.nlm.nih.gov/pubmed/25505969
http://dx.doi.org/10.1038/cti.2014.14

Ejemplares similares